Overall impact
B (77)

Commentary

Stratec is a strong overall performer. With a 'B' rating of 77.1 for overall impact (91st percentile compared to all companies), Stratec ranks 17th out of 155 industry peers, behind Edap Tms, Helius Medical Technologies, Non Invasive Monitoring Systems and 13 others, and ahead of Hologic, American Shared Hospital Services, Accuray and 135 others. On top material causes for Stratec's industry (Healthcare Equipment), Stratec performs well in Disease Eradication (81.2 score), Child and Maternal Health (85.9), Technology Innovation (95.5) and 4 other causes where it received an 'A' score. Stratec did not receive a 'D' or 'F' rating on any cause.
Impact
Cause SBS.DE
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
1,395
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
Germany
Share classes
SBS.DE
STSEY
ADR
Description
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Material causes
Ethos considers the following causes material for Stratec, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.